Followers | 806 |
Posts | 30195 |
Boards Moderated | 5 |
Alias Born | 03/22/2016 |
Monday, January 23, 2023 9:14:04 AM
Recent INBX News
- Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off • PR Newswire (US) • 05/10/2024 10:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 08:57:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:42:49 PM
- Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger • PR Newswire (US) • 05/08/2024 08:37:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2024 09:16:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 08:26:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 09:08:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 08:28:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:41:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 07:58:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 11:26:58 PM
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 02/29/2024 10:26:11 PM
- Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results • PR Newswire (US) • 02/28/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 02:12:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 02:10:06 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:12:09 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/06/2024 09:30:12 PM
- Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law Firm • PR Newswire (US) • 01/26/2024 05:12:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/23/2024 10:25:42 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/23/2024 11:38:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 11:35:58 AM
- Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update • Dow Jones News • 01/23/2024 11:05:00 AM
- Wall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and More • IH Market News • 01/23/2024 10:40:18 AM
- Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B • PR Newswire (US) • 01/23/2024 06:00:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM